CSF A-beta42, p-tau, t-tau; amyloid-PET (florbetapir, flutemetamol) and tau-PET (flortaucipir); blood p-tau217 emerging non-invasive AD biomarker.
CSF A-beta42, p-tau, t-tau; amyloid-PET (florbetapir, flutemetamol) and tau-PET (flortaucipir); blood p-tau217 emerging non-invasive AD biomarker.